- Osteoporosis Slideshow Pictures
- Super Foods for Your Bones Slideshow Pictures
- Take the Osteoporosis Quiz
- What is zoledronic acid? What are the uses for zoledronic acid?
- What are the side effects of zoledronic acid?
- What is the dosage for zoledronic acid?
- Which drugs or supplements interact with zoledronic acid?
- Is zoledronic acid safe to take if I'm pregnant or breastfeeding?
- What else should I know about zoledronic acid?
What is zoledronic acid? What are the uses for zoledronic acid?
- Reclast is used for treatment of osteoporosis in men and postmenopausal women as well as Paget's disease.
- It also is used to prevent osteoporosis in postmenopausal women and treatment of steroid-induced osteoporosis.
Treatment of Osteoporosis in Postmenopausal Women
Reclast is indicated for treatment of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, diagnosed by bone mineral density (BMD) or prevalent vertebral fracture, Reclast reduces the incidence of fractures (hip, vertebral and non-vertebral osteoporosis-related fractures). In patients at high risk of fracture, defined as a recent low-trauma hip fracture, Reclast reduces the incidence of new clinical fractures.
Prevention of Osteoporosis in Postmenopausal Women
Reclast is indicated for prevention of osteoporosis in postmenopausal women.
Reclast is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who are expected to remain on glucocorticoids for at least 12 months.
Paget's Disease of Bone
Reclast is indicated for treatment of Paget's disease of bone in men and women. Treatment is indicated in patients with Paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease.
What brand names are available for zoledronic acid?
Is zoledronic acid available as a generic drug?
Do I need a prescription for zoledronic acid?
What are the side effects of zoledronic acid?
The most common adverse reactions of Reclast include:
Other side effects include:
- Joint pain
- Urinary tract infection
- Low levels of phosphate
- Low levels of potassium
- Low blood pressure
- Low magnesium blood levels
Possible serious side effects include:
- Severe bone, joint, and muscle pain may occur.
- Low calcium levels may occur if calcium and vitamin D intake is not adequate.
- Reduced kidney function after administration of Reclast has occurred.
- Patients may experience jaw problems (osteonecrosis of the jaw) associated with delayed healing and infection after tooth extraction.
- Bone, joint, and muscle pain also occur and low-trauma femoral fractures have been reported.
Other important but rare side effects include cases of severe allergic reactions involving:
- Swelling of tongue
- Closure of airways
What is the dosage for zoledronic acid?
- For treatment of postmenopausal osteoporosis, a single 5 mg infusion once a year is recommended.
- For prevention of postmenopausal osteoporosis the recommended dose is 5 mg every two years.
- Paget's disease of bone is treated with a single 5 mg infusion. Patients with Paget's disease should also receive 1500 mg of elemental calcium and 800 IU vitamin D daily, especially during the two weeks after the injection of Reclast.
- For prevention or treatment of steroid-induced osteoporosis, the recommended dose is 5 mg once yearly.
Latest Arthritis News
Daily Health News
Which drugs or supplements interact with zoledronic acid?
- Combining Reclast with aminoglycoside antibiotics such as gentamycin or loop diuretics such as furosemide (Lasix) or bumetanide (Bumex) may lead to reduced calcium in blood.
- Reclast should be used with caution in patients who are taking drugs that affect kidney function because Reclast has been associated with reduced kidney function.
- Since Reclast contains the same active ingredient as zoledronic acid (Zometa), patients treated with Zometa should not receive Reclast.
Is zoledronic acid safe to take if I'm pregnant or breastfeeding?
- Reclast should not be administered to pregnant women. Women of childbearing age should be advised to use a reliable method of birth control.
- It is not known whether Reclast is excreted in human milk. Since many drugs are excreted in human milk, and Reclast binds to bone long-term, Reclast should not be administered to nursing women.
What else should I know about zoledronic acid?
What preparations of zoledronic acid are available?
Solution: 5 mg/100 ml
How should I keep zoledronic acid stored?
- Unopened bottles should be kept at room temperature 15 C-30 C (59 F-86 F).
- Opened bottles of solution are stable for 24 hours at 2 C-8 C (36 F-46 F).
Reclast (zoledronic acid) is an injectable drug in a class of drugs referred to as bisphosphonates. It is prescribed for the treatment of osteoporosis in postmenopausal women and men, Paget's disease of bone in men and women, osteoporosis prevention in postmenopausal women, and the treatment of steroid-induced osteoporosis. Side effects include
- Pain in the feet or hands
Drug interactions, warnings and precautions, dosage, and pregnancy and breastfeeding safety information should be reviewed prior to taking any medication.
Multimedia: Slideshows, Images & Quizzes
Osteoporosis Quiz: What is Osteoporosis?
What are the causes, symptoms, and risk factors of osteoporosis? Quiz yourself about vitamin deficiency, maintaining bone...
Picture of Osteoporosis
Thinning of the bones with reduction in bone mass due to depletion of calcium and bone protein. See a picture of Osteoporosis and...
Related Disease Conditions
Learn about osteoporosis, a condition characterized by the loss of bone density, which leads to an increased risk of bone fracture. Unless one experiences a fracture, a person may have osteoporosis for decades without knowing it. Treatment for osteoporosis may involve medications that stop bone loss and increase bone strength and bone formation, as well as quitting smoking, regular exercise, cutting back on alcohol intake, and eating a calcium- and vitamin D-rich balanced diet.
Paget's disease is a chronic bone disorder due to irregular breakdown and formation of bone tissue. Symptoms of Paget's disease include bone pain, headaches and hearing loss, pressure on nerves, increased head size, hip pain, and damage to cartilage of joints.
Menopause is the time in a woman's life when menstrual periods permanently stop, also called the "change of life." Menopause symptoms include hot flashes, night sweats, irregular vaginal bleeding, vaginal dryness, painful intercourse, urinary incontinence, weight gain, and emotional symptoms such as mood swings. Treatment of menopausal symptoms varies, and should be discussed with your physician.
Disease Prevention in Women
Disease prevention in women includes screening tests that are a basic part of prevention medicine. All screening tests are commonly available through your general doctor. Some specialized tests may be available elsewhere.
Premature Menopause (Symptoms, Causes, and Treatments)
Premature menopause is when menopause occurs in a woman before the age of 40. Causes of premature menopause include premature ovarian failure, treatments for cancer and other conditions, surgical removal of the ovaries, or chronic diseases of the pituitary or thyroid gland, or psychiatric disorders. Treatment is directed at menopausal symptoms.
Male menopause refers to the decline in testosterone production in men. As men age, they often experience many of the same symptoms that women experience in menopause. Testosterone replacement therapy may relieve some of these symptoms.
Osteopenia is a bone condition characterized by bone loss that is not as severe as in osteoporosis. Bone fracture is the typical symptom of osteopenia, though the condition may be present without symptoms. Treatment involves lifestyle modifications (quitting smoking, not drinking in excess) and ensuring an adequate intake of vitamin D and calcium.
Osteoarthritis vs. Osteoporosis Differences and Similarities
Arthritis is defined as painful inflammation and joint stiffness. Osteoarthritis is a type of arthritis and the most common cause of chronic joint pain, affecting over 25 million Americans. Osteoarthritis is a type of arthritis that involves the entire joint. Osteoporosis is not a type of arthritis. It is a disease that mainly is caused by a loss of bone tissue that is not limited to the joint areas. It is possible for one person to have both osteoarthritis and osteoporosis. The differences in the signs and symptoms of osteoarthritis and osteoporosis include; pain, stiffness, and joint swelling, joint deformity, crackle sounds when the joint is moving, and walking with a limp. Osteoporosis is called the "silent disease" because it can progress for years without signs and symptoms before it is diagnosed, severe back pain, bone fractures, height loss, and difficulty or inability to walk. The differences in the causes of osteoarthritis and osteoporosis are that osteoarthritis usually is caused by wear and tear on the joints. Osteoporosis usually is caused by one or more underlying problems, for example, calcium and vitamin D deficiencies. Treatment for osteoarthritis and osteoporosis are not the same. There is no cure for osteoarthritis or osteoporosis.
Treatment & Diagnosis
Medications & Supplements
Prevention & Wellness
- Powerful Drug for Advanced Cancers May Need Less Frequent Dosing
- Certain Generic Meds May Help Older Patients With Early Breast Cancer
- Early Chemo May Boost Survival in Advanced Prostate Cancer
- Bone-Building Drug Strengthened Hips, Spines of Frail Women in Study
- Bone Drugs Don't Lower Breast Cancer Risk After All, Study Finds
- Men May Benefit From Osteoporosis Drug, Too: Study
- Newer Bone Drug Better for Advanced Breast Cancer Patients: Study
- Bone Drugs May Also Battle Breast Cancer, Researchers Say
- Osteoporosis Drugs' Safety Subject of FDA Panel
- FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk
- Osteoporosis Drugs Linked to Rare Fractures
- Only Rare Fractures Linked to Osteoporosis Drugs
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Some content is courtesy of the U.S. Food and Drug Administration